HTLV-I Associated Myelopathy: A Case of Viral-Induced Auto-Immunity

References

• Gcssain A., Barin F., Vernant J C.O., Maurs Gout L., Calemder A., De The G. Antibodies to the human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet 1985; ii: 407–409
   Google Scholar
• Osame M, Usku K., Izumo S., Ijichi S., Amitani H., Igata A., Matsumoto M., Tara M. HTLV-I associated myelo-pathy, a new clinical entity. Lancet 1986; i: 1031–1032
   Google Scholar
• Robert-Guroff M, Hakao Y., Notake K., Ito Y., Sliski A., Gallo R C. Natural antibodies to human retrovirus HTLV in a cluster of Japanese patients with adult leukemia. Science 1982; 215: 95–98
   Google Scholar
• Yoshida M, Seiki M., Yamaguchi K., Takatsuki K. Monoclonal integration of human T-cell leukemia provirus in all primary tumors of adult T-cell leukemia suggests causative role of human T-cell leukemia virus in the disease. Proc. Natl Acad. Sci. USA 1984; 81: 2543–2537
   Google Scholar
• Oger J., Werker D H., Foti D J., Dekaban G. HTLV-I Associated Myelopathy: an endemic disease of Canadian Aboriginals of the Northwest. Pacific Coast. Can. J. Neural Sci 1993; 20: 302–306
   Web of Science ®Google Scholar
• Poiesz BJ., Ruscetti F W., Gazdar A F., Bunn P A., Minna J D., Gallo R C. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc. Natl Acad. Sci. USA 1980; 77: 7415–7419
   PubMed Web of Science ®Google Scholar
• Cullen B. Human Immunodeficiency Virus as a prototypic complex retrovirus 1991; 65: 1053–1056
   Google Scholar
• Niewiesk S., Daenke S., Parker C E., Taylor G., Weber J., Nightingale S., Baryhorn C R.M. The transastivator gene of Human T-cell leukemia virus type I is more variable within and between healthy carriers than patients with tropical spastic paraparesis. J. Virol 1994; 68: 6778–6781
   Google Scholar
• Flier J S., Underhill L H., Hafler D A. Patho-genesis of diseases induced by Human Lymphotropic virus type I infection. N.E.J.M 1993; 328: 1173–1182
   PubMed Web of Science ®Google Scholar
• Roithmann S., Pique C., LeCesne A., Delamarre L., Pham D., Tursz T., Dokhelar M-C. The open reading frame I (ORF 1)/ORF II part of the human T-cell leukemia virus type 1 X region is deispensable for p40^Tax and p27^rex or envelope expression 1994
   Google Scholar
• Mulloy JC, Boeri E., Gallo R C, Leonard W J., Fran-Chini G. The HTLV-1 p12 protein binds to the immature forms of the IL-2 receptor beta and gamma chains: Possible implication in IL-2R signaling. AIDS Res. and Hum. Retro 1994; 10: 443
   Google Scholar
• Mann A., Blattner W A. The epidemiology of the human T-cell lymphotropic virus type-I and II: etiologic role in human disease. Transfusion 1991; 31: 67–75
   Google Scholar
• Blattner WA., Nomura A., Clark J., Ho G., Nakao Y., Gallo R C., Robert-Guroff M. Modes of transmission and evidence for viral latency from studies of human T-cell lymphotropic virus type-I in Japanese migrant populations in Hawaii. Proc. Natl Acad. Sci. USA 1986; 83: 4895–4898
   Google Scholar
• Kinoshita A., Amagasaki T., Hino S., Dio H., Yamanouchi K., Ban N., Momita S., Ikeda S., Kamihira S., Ichimaru M., Katamine S., Miyamoto T., Tsuji Y., Ishimaru T., Yamabe T., Ito M., Kamura S., Tsuda T. Milk-borne transmission of HTLV-I from carrier mothers to their children. Japan. J. Vir. Res 1987; 78: 674–680
   Google Scholar
• Iwasaki Y. Neuropatholgy of HAM/TSP in Japan Proc. of 1st Int workshop on neuropathology of Retrovirus infections. Tokyo University Press. 1989; volume 131
   Google Scholar
• Bhigjee A I., Wiley C A., Wachsman W., Matthias D A., Amenomori T., Pirie D D., Bill P L.K.A., Windsor I M. HTLV-I associated myelopathy: Clinicopathologic correlation with localization of provirus to spinal cord. Neurology 1991; 41: 1990–1992
   Google Scholar
• Kira J., Itoyama Y., Koyanagi Y., Tateishi J., Kishikawa M., Akizuki S., Kobayashi I., Toki N., Sueishi K., Sato H., Sakaki Y., Yamamoto N., Goto I. Presence of HTLV-I proviral DNA in central nervous system of patients with HTLV-I associated myelopathy. Ann. Neurol 1992; 31: 39–45
   PubMedGoogle Scholar
• Wu E, Dickson D W., Jacobson S., Raine C S. Neuroaxonal dystrophy in HTLV-I-associated myelopathy/tropical spastic paraparesis: neuropathologic and neuroimmunologic correlations. Acta. Neuropathol. Bed. 1993; 86(3)224–235
   Google Scholar
• Iwasaki Y., Ohara Y., Kobayashi I., Akizuki S I. Infiltration of helper/inducer T-lymphocytes heralds central nervous system damage in human T-cell leukemia virus infections. Am. J. Pathol 1992; 140: 1003–1008
   PubMed Web of Science ®Google Scholar
• Yoshioka A., Hirose G., Ueda Y., Nishimura Y., Sakai K. Neuropathological studies of the spinal cord in early stage HTLV-I-associated myelopathy (HAM). J. Neurol. Neurosurg. Psychiatry 1993; 56(9)1004–1007
   Google Scholar
• Ishiguro K, Abe M., Seto K., Sakuri H., Ikeda H., Wakisaka A., Togashi T., Tateno M., Yoshiki T. A rat model of human T lymphocyte virus type I (HTLV-I) infection. 1. Humoral antibody response, provirus integration, and HTLV-I associated myelopathy/tropical spastic paraparesis-like myelopathy in seronegative HTLV-I carriers rats. J. Exp. Med 1992; 176: 981–989
   PubMedGoogle Scholar
• Kushida S., Mizusawa H., Matsumura M., Tanaka H., Ami Y., Hori M., Yagami K I., Kameyama T., Tanaka Y., Yoshida A., Nyunoya H., Shimotohno K., Iwasaki Y., Uchida K., Miwa M. High incidence of HAM/TSP-like symptoms in WKA rats after administration of human T-celHeukemia virus Type 1-producing cells. J. Virol 1994; 68: 7221–7226
   PubMedGoogle Scholar
• Achiron A., Pinhas Hamiel, Dull L. Spastic Paraparesis Associated with Human T Lymphotropic Virus Type I: A Clinical, Serological and Genomic Study in Iranian-born Mashhadi Jews. Ann. Neurol 1993; 34: 670–675
   Google Scholar
• Kaplan J E., Osame M. The risk of development of HTLV-I Associated Myelopathy/Tropical Spastic Paraparesis among persons infected with HTLV-I. Journal of Acquired Immune Deficiency Syndromes 1990; 3(11)1096–1101
   PubMed Web of Science ®Google Scholar
• Sonada J., Yashiki S., Fujiyoshi T., Osame M., Tanaka H., Zaninovic V., Blank M., Blank A., Hayami M., Tajima K. Genetic Background of ATL and HAM/TSP among Japanese and other ethnic groups. J AIDS. Rsearch 1994; 10: 452
   Google Scholar
• Komurian F., Pelloguin F., De The G. In vivogenomic variability of human T-cell leukemia vieus type I depends more upon geography than upon pathologies. J. Virol 1991; 65: 3770–3778
   Google Scholar
• Kinoshita T., Tsujimoto A., Shimotohno K. Sequence variations in LTR and regions of HTLV-I do not discriminate between the virus from patients with HTLV-I associated myelopathy and adult T-Cell leukemia. Int. J. Cancer 1991; 47: 491–495
   PubMedGoogle Scholar
• Szurek P F., Yuen P H., Jergy R., Wong P K.Y. Identification of point mutations in the envelope gene of Maloney murine leukemia virus TB temperature sensitive paralyto-genic mutant tsl: Molecular determinants for neuroviru-lencc. J. Virol 1988; 62: 357–360
   Google Scholar
• Rerjifo B., Borrero I., Essex M. Tax mutation associated with tropical spastic paraparesis/human T-cell leukemia virus type I-associated myelopathy. J. Virol 1995; 69: 2611–2616
   Google Scholar
• Niewiesk S., Daenke S., Parker C E., Taylor G., Weber J., Nightingale S., Baryham C R.M. The transactivator gene of human T-cell leukemia virus type I is more variable within and between healthy carriers than patients with tropical spastic paraparesis. J. Virol 1994; 68: 6778–6781
   Google Scholar
• Watabe K., Saida T., Kim S U. Human and simian glial cells infected by human T-lymphotropic virus type I in culture. J. Neuropathol. Exp. Neurol. (United States) 1989; 48(6)610–619
   Google Scholar
• Graziani G., Faraoni I., Zhand H., Caronti B., Lauro G., Bonmassar E., Macchi B. Transient HTLV-I infection of a human glioma cell line following cell-free exposure. Virology 1993; 197: 767–769
   Google Scholar
• Lehky T J., Cowan E P., Lampson L A., Jacobson S. Induction of HLA class I and class II expression in human T-lymphotropic virus type I-infected neuroblastoma cells. J. Virol 1994; 68(3)1854–1863
   Google Scholar
• Iwasaki Y. Human T-cell leukemia virus type I infection and chronic myelopathy. Brain Pathol 1993; 3(1)1–10
   Google Scholar
• Yoshioka A., Hirose G., Ueda Y., Nishimura Y., Sakai K. Neuropathological studies of the spinal cord in early stage HTLV-I-associated myelopathy (HAM). J. Neurol. Neurosurg. Psychiatry 1993; 56(9)1004–1007
   Google Scholar
• Hara H., Orita M., Iwaki T., Hatoe T., Itoyama Y., Kita-Moto T., Akizuki S I., Goto I., Watanabe T. Detection of human T-lymphocytic virus type I (HTLV-I) paraviral DNA and analysis of T-cell receptor Vβ CDR3 sequence in spinal cord lesions of HTLV-I associated myelopathy/ Tropical spastic paraparesis. J. Exp. Med 1994; 180: 831–839
   Google Scholar
• Lehky T J., Fox C H., Koening S. Detection of human T-lymphotropic virus type I (HTLV-I) Tax RNA in the central nervous system of HTLV-I associated myelopathy/ tropical spastic paraparesis patients by in situ hybridization. Ann. Neurol 1995; 37: 167–175
   PubMed Web of Science ®Google Scholar
• Tatal N., Gary R F., Schur P H., Alexander S S., Dauphinee M J., Livas K., Dang H. A conserved idiotype and antibodies to retroviral proteins in systemic lupus erythe-matosus. J. Clin. Invest 1990; 85: 1866–1871
   Google Scholar
• Maul G G, Jimenez S A., Riggs E., Ziemnicka-Zotula D. Determination of an epitope of the diffuse systemic sclerosis marker antigen DNA topoisomerase I: Sequence similarity with retroviral p30 gag protein suggests a possible cause for autoimmunity in systemic sclerosis. Proc. Natl Acad. Sci. USA 1989; 86: 8492–8496
   PubMed Web of Science ®Google Scholar
• Garry R F. Extensive antigenic mimicry by retroviral capid proteins. Aids Res. Hum. Retroviruses 1990; 1361–1362
   Google Scholar
• Query C., Keene J D. A human autoimmune protein associated with UIRNA contains a region of homology that is cross-reactive with retroviral p30 gag antigen. Cell 1987; 51: 211–220
   PubMed Web of Science ®Google Scholar
• Kohsaka H., Yamamoto K., Fuji H., Miura H., Miasaka N., Nihioka K., Miyamoto T. Fine epitope mapping of the human SS-β/La protein: Identification of a distinct autoepitope homologous to a viral gag polyprotein. J. Clin. Invest 1990; 85: 1566–1574
   PubMed Web of Science ®Google Scholar
• Haynes B F., Robert-Guroff M., Metzgar R S., Franchini G., Kalyanarasnan U S., Palker T J., Gallo R C. Monoclonal antibody aganist human leukemia virus p19 defines a human thymic epithelial antigen acquired during ontogeny. J. Exp. Med 1983; 157: 907–920
   Google Scholar
• Parker T J., Scearce R M., Ho W., Copeland T D., Oroszlan S., Popovic M., Haynes B F. Monoclonal antibodies reactive with human T-cell lymphotropic virus I (HTLV-I) internal core protein: Cross reactivity with normal tissues and differential reactively with HTLV types I and II. J. Immunol 1985; 135: 247–254
   Google Scholar
• Hickey W. Migration of hematogenous cells through the blood-brain barrier and imitation of CNS inflammation. Brain Pathol 1991; 1: 97–106
   PubMed Web of Science ®Google Scholar
• Weinshenker B., Rice G P.A. Retroviral disease of the nervous system. Myelination and demyelnation, S U. Kim. Plenum Pub. Corp, NY 1989; 145–152
   Google Scholar
• Hickey W., Hsu B., Kimura H. T-lymphocytes entry into the central nervous system. J. Neurosci. Res 1991; 28: 254–260
   PubMed Web of Science ®Google Scholar
• Patey O., Gessain A., Breuil J. Seven years of recurrent severe strongyloidiasis in an HTLV-I infected man who developed Adult T-cell leukaemia. AIDS (United States) 1992; 6: 575–579
   Google Scholar
• Patey O., Gessain A., Breuil J., Courillon-Mallet A., Daniel M-T., Miclea J M., Roucayrol A-M., Sigaux F., Lafaix C. Seven years of recurrent severe strongyloidiasis in an HTLV-I infected man who developed adult T-ceil leukemia. AIDS 1992; 6: 575–579
   Web of Science ®Google Scholar
• LaGrenade L., Hanchard B., Fletcher V., Cranston B., Blattner W A. Infective dermatitis of Jamaican children: a marker of HTLV-I infection. Lancet 1991; 33: 1345–1347
   Google Scholar
• Ijichi S., Matsuda T., Maruama I., Izumihara T., Kojima K., Niimura T., Maruyama Y., Sonoda S., Yosida A., Osame M. Arthritis in a human T lymphotropic virus type I HTLV-1 carriers. Ann. Rheumatol 1991; 162: 435–440
   Google Scholar
• Mochizuki M., Watanabe T., Yamaguchi K., Yoshimura K., Nakashima S., Shirao M., Araki S., Takatsuki K., Mori S., Miyata N. Uvcitis associated with human T-cell lymphotropic virus Type 1. Am. J. Ophthal 1992; 114: 123–129
   PubMed Web of Science ®Google Scholar
• Sowa J M. Human T lymphocyte virus 1, myelopathy, polymyositis and synovitis: an expanding rheumatic spectrum. J. Rheum 1991; 19: 316–318
   Google Scholar
• Mann D L, DeSantis P., Mark G., Pfeifer A., Newman M., Gibbs N., Popovic M., Sarngadharan M G., Gallo R C., Clark J., Blattner W. HTLV-I associated B-cell CII: Indirect role for retrovirus in leukemogenesis. Science 1987; 236: 1103–1106
   PubMed Web of Science ®Google Scholar
• Miyazaki K., Yamaguchi K., Tohya T., Ohba T., Takatsuki K., Okamura H. Human T-cell leukemia virus type 1 infection as an oncogenic prognostic risk factor in cervical and vaginal carcinoma. Obstet. Gyneol 1991; 77: 107–110
   PubMed Web of Science ®Google Scholar
• Kuroda Y., Fujiyama F., Nagumo F. Analysis of factors of relevance to rapid progression in HTLV-I associated myelopathy. J. Neurol. Sci. (Netherlands) 1991; 105: 61–66
   Google Scholar
• Welles S L., Tachibana N., Okayama A., Shioiri S., Ishihara S., Murai K., Mueller N E. Decreased reactivity to PPD among HTLV-I carriers in relation to virus and hematologic status. Int. J. Cancer 1994; 56: 337–340
   Google Scholar
• Itomaya Y., Minato S., Kira J J. Spontaneous proliferation of peripheral blood leukocytes increased in patients with HTLV-I associated myelopathy. Neurology 1988; 38: 1302–1307
   Google Scholar
• Knight S C., Macatonia S E., Cruickshank K., Rudge P., Patterson S. Dendritic cells in HTLV-1 and HTLV-I infection. Adv. Exp. Med. Biol 1993; 329: 545–9
   Google Scholar
• Steinman R M., Cohn Z A. Identification of a novel cell type in lymphoid organs of mice. J. Exp. Med 1993; 137: 1142–1162
   Google Scholar
• Ali A., Patterson S., Cruickshank K., Rudge P., Dalgleish A G., Knight S C. Dendritic cells infected in vitro with human T-ccll lcukaemia/lymphoma virus type-1 (HTLV-I); enhanced lymphocytic proliferation in tropical spastic para-parcsis. Clin. Exp. Immunol 1993; 94(1)32–37
   Google Scholar
• Kimata J T., Palker T J., Ratner L. The mitogenic activity of human T-cell leukemia virus type I is T-cell associated and requires the CD2/LFA-3 activation pathway. J. Virol 1993; 67(6)3134–3141
   Google Scholar
• Natazuka T., Umemiya-Okada T., Matsui T. FK506 and Cyclosporin A regulate proliferation and proto-oncogene expression in HTLV-I associated myelopathy/ tropical spastic paraparesis derived T-cells. International Journal of Cancer 1993; 54(2)348–354
   Google Scholar
• Dhawan S., Weeks B S., Abbasi F., Gralnick H R., Notkins A L., Klotman M E., Yamada K M., Klotman P E. Increased expression of alpha 4 beta 1 and alpha 5 beta 1 Integrins on HTLV-I-infected lymphocytes. Virology 1993; 197(2)778–781
   Google Scholar
• Huynh H K., Dorovini-Zis K. Effect for Interferon Gamma and Beta on the adhesion and migration of lymphocytes across human brain endothelial cells in vitro. Can. J. Neurol. Sci 1994; 21: S104
   Google Scholar
• Anderson E C., Christensen J P., Marker O., Thomsen A R. Changes in cell adhesion molecule expression on T-cells associated with systemic viral infection. J Immunol 1994; 152: 1237–1245
   Google Scholar
• Lehky T J., Cowan E P., Lampson L A. Induction of HLA class I and class II expression in human T-lympho-tropic virus type I-infected neuroblastoma cells. J. Virol 1994; 68(3)1854–1863
   Google Scholar
• Burns J B., Littlefield K. Human T lymphocytes reactive with whole myelin recognize predominantly myelin basic protein. J. Neuroimmunol. (Netherlands) 1989; 24(1–2)67–74
   Google Scholar
• Koenig S., Woods R M., Brewah Y A., Newell A J., Jones G M., Boone E., Adelsberger J W., Baseler M W., Robinson S M., Jacobson S. Characterization of MHC class I restricted cytotoxic T-cell responses to Tax in HTLV-I infected patients with neurologic disease. J. Immunol 1993; 151(7)3874–3883
   Google Scholar
• Elovaara I., Koenig S., Brewah A Y., Woods R M., Lehky T., Jacobson S. High human T-cell lymphotropic virus type 1 (HTLV-I)-specific precursor cytotoxic T lymphocyte frequencies in patients with HTLV-I-associated neurological disease. J. Exp. Med 1993; 177(6)1567–1573
   Google Scholar
• Parker C E., Daenke S., Nightingale S., Bengham C P.M. Activated, HTLV-I specific cytotoxic T-lymphocytes are found in healthy seropositives as well as in patients with tropical spastic paraparesis. Virology 1992; 188: 628–636
   PubMed Web of Science ®Google Scholar
• Parker C E., Nightingale S., Taylor G P., Weber J., Bangham C R.M. Circulating anti-Tax cytotoxic T lymphocytes from human T-cell Leukamia virus type I infected people, with and without tropical spastic paraparesis, recognize multiple epitopes simultaneously. J. Virol 1994; 68: 2860–2868
   Google Scholar
• Karjalainen H E., Tevethia M J., Tevethia S L. Abrogation of simian virus 40 DNA mediated transformation of primary C57BL/6 mouse embryo fibroblasts by explosure to a simian virus 40 specific cytotoxic T-lymphocytes alone. J. Virol 1985; 56: 373–377
   Google Scholar
• Kast W M., Offringa R., Peters P J., Voordouw A C., Mrloen R H., van der Ebb A J., Melief C J.M. Eradication of adenovirus El induced tumors by E-1A specific CTL. Cell 1989; 59: 603–614
   PubMed Web of Science ®Google Scholar
• Gavioli R., Kurilla M G., Composlima P O.D., Wallace L E., Dolaclli R., Murray R J., Rickinson A B., Masucci M G. Multiple HLA-A11 restricted cytotoxic T-lymphocyte epitopes of different immunogenicities in the Ebstein Barr virus-encoded nuclear antigen 4. J. Virol 1993; 67: 1572–1578
   PubMed Web of Science ®Google Scholar
• Murray R J., Kurilla M G., Brooks J M., Thomas W A., Rowe M., Kieff E., Rickinson A B. Identification of target antigens for the human cytotoxic T-cell response to Epstein-Barr virus (EBV) 8 implications for the immune control of EBV-positive malignancies 1992
   Google Scholar
• Hoffman P M., Cimino E F., Roblins D S. Effects of viral specific cytotoxic lymphocytes on the expression of murine leukemia virus induced neurologic disease. J. Neuroimmunol 1991; 33: 157–165
   Google Scholar
• Jacobson S., Shida H., McFarlin D E., Fauci A., Koenig S S. Circulating CD8 + cytotoxic T lymphocytes specific for HTLV-I pX in patients with HTLV-I associated neurological disease. (London Nature) 1990; 348: 245–248
   PubMed Web of Science ®Google Scholar
• Tendler C L., Greenberg S J., Burton J D., Danielpour D., Kim J-M., Blattner W A., Manns A., Waldmann T A. Cytokine induction in HTLV-I associated myelopathy and adult T-cell leukemia: alternate molecular mechanisms underlying retroviral pathogenesis. J. Cellular Biochem 1991; 46: 302–311
   PubMedGoogle Scholar
• Baggiolini M., Dewald B., Hoaer B. Interleukin-8 and related chemotactic cytokines. CXC and CC chemokines. Adv. Immunol 1994; 544: 97–179
   Google Scholar
• Ransohoff R M., Hamilton T A., Tani M., Stoler M H., Shick H E., Major J A., Estes M L., Thomas D M., Tuohy V K. Astrocyte expression of mRNA encoding cytokine IP-10 and JE/MCP-1 in experimental autoimmune enceph-alomyelitis. The FASEB J. 1993; 7: 592–600
   PubMed Web of Science ®Google Scholar
• Taub D D., Lloyd A R., Wang J M., Oppenheim J J., Kelvin D J. The effects of human recombinant MlP-Ia, M1P-I b and RANTES on the chemotaxis and adhesion of T-cell subsets. Proc. 3rd Int. symp. on chemotactic cytokines. In. Biology of the inflammatoy peptide supegene family 1994; II: 139
   Google Scholar
• Taub D D., Lloyd A R., Conlon K., Wang J M., Ortaldo J R., Harda A., Matsushima K., Kelvin D J., Oppenheimer J J. Recombinant IP-10 is a chemoattractant for human monocytes and T lymphocytes and promotes T cell adhesion to endothelial cells. J. Exp. Med 1993; 177: 1809–1814
   PubMed Web of Science ®Google Scholar